BE1005511A4 - Utilisation de nouvelles microspheres injectables biodegradables, procede de preparation de ces nouvelles microspheres et suspensions injectables les renfermant. - Google Patents
Utilisation de nouvelles microspheres injectables biodegradables, procede de preparation de ces nouvelles microspheres et suspensions injectables les renfermant. Download PDFInfo
- Publication number
- BE1005511A4 BE1005511A4 BE9001062A BE9001062A BE1005511A4 BE 1005511 A4 BE1005511 A4 BE 1005511A4 BE 9001062 A BE9001062 A BE 9001062A BE 9001062 A BE9001062 A BE 9001062A BE 1005511 A4 BE1005511 A4 BE 1005511A4
- Authority
- BE
- Belgium
- Prior art keywords
- radical
- carbon atoms
- microspheres
- sep
- hydrogen atom
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR898914976A FR2654337B1 (fr) | 1989-11-15 | 1989-11-15 | Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant. |
Publications (1)
Publication Number | Publication Date |
---|---|
BE1005511A4 true BE1005511A4 (fr) | 1993-08-31 |
Family
ID=9387417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE9001062A BE1005511A4 (fr) | 1989-11-15 | 1990-11-09 | Utilisation de nouvelles microspheres injectables biodegradables, procede de preparation de ces nouvelles microspheres et suspensions injectables les renfermant. |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPH03294229A (de) |
AT (1) | AT400298B (de) |
BE (1) | BE1005511A4 (de) |
CA (1) | CA2029940A1 (de) |
CH (1) | CH681691A5 (de) |
DE (1) | DE4036425A1 (de) |
DK (1) | DK270990A (de) |
FR (1) | FR2654337B1 (de) |
GB (1) | GB2239798B (de) |
IT (1) | IT1242010B (de) |
LU (1) | LU87836A1 (de) |
NL (1) | NL9002492A (de) |
SE (1) | SE9003570L (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA924811B (en) * | 1991-06-28 | 1993-12-29 | Endorecherche Inc | Controlled release systems and low dose androgens |
HU222501B1 (hu) * | 1991-06-28 | 2003-07-28 | Endorecherche Inc. | MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására |
ES2105525T3 (es) * | 1993-06-24 | 1997-10-16 | Lilly Co Eli | 2-fenil-3-aroilbenzotiofenos antiestrogenicos como agentes hipoglicemicos. |
US5910492A (en) * | 1995-06-05 | 1999-06-08 | Takeda Chemical Industries, Ltd. | Osteogenic promoting pharmaceutical composition |
EP2210585A1 (de) | 2009-01-16 | 2010-07-28 | Exelgyn | Pharmazeutische SPRM-Zusammensetzungen, Behandlungsverfahren unter Anwendung dieser |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2070153A1 (de) * | 1969-10-23 | 1971-09-10 | Du Pont | |
FR2537980A1 (fr) * | 1982-12-17 | 1984-06-22 | Sandoz Sa | Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation |
GB2160873A (en) * | 1984-06-29 | 1986-01-02 | Roussel Uclaf | 11B-(4-Aminophenyl) estra-4,9-dienes |
EP0196707A1 (de) * | 1982-06-11 | 1986-10-08 | Roussel-Uclaf | In Stellung 11 und 17 und gegebenenfalls in Stellung 2 substituierte 19-Nor-Steroide, ihre Herstellung, ihre Anwendung als Arzneimittel, die sie enthaltenden Zusammensetzungen und die erhaltenen Zwischenprodukte |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4293539A (en) * | 1979-09-12 | 1981-10-06 | Eli Lilly And Company | Controlled release formulations and method of treatment |
US4389330A (en) * | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
ZA8231B (en) * | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
US4530840A (en) * | 1982-07-29 | 1985-07-23 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
ES8502612A1 (es) * | 1983-06-15 | 1985-02-01 | Schering Ag | Procedimiento para la preparacion de 13a-alquilgonanos |
GB8327256D0 (en) * | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
JPS60100516A (ja) * | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
DE3347126A1 (de) * | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate |
CA1256638A (en) * | 1984-07-06 | 1989-06-27 | Motoaki Tanaka | Polymer and its production |
FR2573657B1 (fr) * | 1984-11-29 | 1989-05-12 | Roussel Uclaf | Produit comprenant une substance antiprogestomimetique et une substance uterotonique |
DE3533175A1 (de) * | 1985-09-13 | 1987-03-19 | Schering Ag | Antigestagene zur verschiebung der endometrialen reifung |
FR2596395B1 (fr) * | 1986-03-26 | 1989-05-26 | Roussel Uclaf | Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant |
US4758435A (en) * | 1986-08-11 | 1988-07-19 | American Cyanamid Company | Estradiol implant composition and method for preparation |
DE3633244A1 (de) * | 1986-09-26 | 1988-03-31 | Schering Ag | Antigestagene zur hemmung der uterinen prostaglandinsynthese |
EP0310542B1 (de) * | 1987-10-01 | 1994-06-08 | Schering Aktiengesellschaft | Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren |
DE3733478A1 (de) * | 1987-10-01 | 1989-04-13 | Schering Ag | Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore |
DE3744054A1 (de) * | 1987-12-21 | 1989-06-29 | Schering Ag | Verwendung von antigestagenen zur herstellung von arzneimitteln |
JP2785023B2 (ja) * | 1987-12-30 | 1998-08-13 | ルセル―ユクラフ | 17α位置を置換された17β―OH―19―ノルステロイドの新誘導体、その製造方法、その薬剤としての使用及びそれを含有する製薬組成物 |
JP2670680B2 (ja) * | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
-
1989
- 1989-11-15 FR FR898914976A patent/FR2654337B1/fr not_active Expired - Fee Related
-
1990
- 1990-11-08 LU LU87836A patent/LU87836A1/fr unknown
- 1990-11-09 BE BE9001062A patent/BE1005511A4/fr not_active IP Right Cessation
- 1990-11-09 SE SE9003570A patent/SE9003570L/ not_active Application Discontinuation
- 1990-11-13 IT IT48470A patent/IT1242010B/it active IP Right Grant
- 1990-11-13 DK DK270990A patent/DK270990A/da not_active Application Discontinuation
- 1990-11-14 CA CA002029940A patent/CA2029940A1/fr not_active Abandoned
- 1990-11-14 CH CH3611/90A patent/CH681691A5/fr not_active IP Right Cessation
- 1990-11-14 JP JP2306374A patent/JPH03294229A/ja active Pending
- 1990-11-15 AT AT0231390A patent/AT400298B/de not_active IP Right Cessation
- 1990-11-15 NL NL9002492A patent/NL9002492A/nl not_active Application Discontinuation
- 1990-11-15 DE DE4036425A patent/DE4036425A1/de not_active Withdrawn
- 1990-11-15 GB GB9024862A patent/GB2239798B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2070153A1 (de) * | 1969-10-23 | 1971-09-10 | Du Pont | |
EP0196707A1 (de) * | 1982-06-11 | 1986-10-08 | Roussel-Uclaf | In Stellung 11 und 17 und gegebenenfalls in Stellung 2 substituierte 19-Nor-Steroide, ihre Herstellung, ihre Anwendung als Arzneimittel, die sie enthaltenden Zusammensetzungen und die erhaltenen Zwischenprodukte |
FR2537980A1 (fr) * | 1982-12-17 | 1984-06-22 | Sandoz Sa | Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation |
GB2160873A (en) * | 1984-06-29 | 1986-01-02 | Roussel Uclaf | 11B-(4-Aminophenyl) estra-4,9-dienes |
Also Published As
Publication number | Publication date |
---|---|
CA2029940A1 (fr) | 1991-05-16 |
FR2654337B1 (fr) | 1994-08-05 |
DK270990D0 (da) | 1990-11-13 |
NL9002492A (nl) | 1991-06-03 |
IT1242010B (it) | 1994-02-02 |
LU87836A1 (fr) | 1991-05-07 |
IT9048470A1 (it) | 1992-05-13 |
ATA231390A (de) | 1995-04-15 |
AT400298B (de) | 1995-11-27 |
IT9048470A0 (it) | 1990-11-13 |
SE9003570D0 (sv) | 1990-11-09 |
CH681691A5 (de) | 1993-05-14 |
GB9024862D0 (en) | 1991-01-02 |
FR2654337A1 (fr) | 1991-05-17 |
JPH03294229A (ja) | 1991-12-25 |
GB2239798B (en) | 1993-10-27 |
GB2239798A (en) | 1991-07-17 |
SE9003570L (sv) | 1991-05-16 |
DK270990A (da) | 1991-05-16 |
DE4036425A1 (de) | 1991-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE1004486A3 (fr) | Formulations a liberation prolongee de peptides solubles dans l'eau. | |
US4801739A (en) | Oligomeric hydroxycarboxylic acid derivatives, their production and use | |
EP1450766B1 (de) | Biologisch abbaubare mikrokügelchen mit verlängerter freisetzung und verfahren zu ihrer herstellung | |
WO1991015193A1 (fr) | Microspheres, leur procede de preparation et leur utilisation | |
FR2810885A1 (fr) | Microparticule a liberation soutenue et procede de fabrication | |
FR2484281A1 (fr) | Procede de preparation de microspheres comportant un noyau solide et une matiere polymere | |
BE1005511A4 (fr) | Utilisation de nouvelles microspheres injectables biodegradables, procede de preparation de ces nouvelles microspheres et suspensions injectables les renfermant. | |
WO2003004024A1 (fr) | Microspheres injectables a liberation prolongee de composes d'huperzine a | |
EP3970698A1 (de) | Injizierbare zusammensetzung mit prodrug von caspase-inhibitoren und herstellungsverfahren dafür | |
BE1001687A5 (fr) | Composition a base de polyesters pour la liberation controlee de substances medicamenteuses. | |
EP0543713A1 (de) | Ethanolaminbenzoatderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
BE898430A (fr) | Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation. | |
US20020041897A1 (en) | Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same | |
CN113845474A (zh) | 一种抗抑郁活性物质BHC-one及其制备与应用 | |
EP0151140B1 (de) | Salz von 2-piperazinopyrimidin, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammenstellungen | |
JPS6341416A (ja) | 鎮痛性ペプチド含有マイクロカプセルの製造法 | |
FR2801055A1 (fr) | Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique | |
JP2013538855A (ja) | 低い残留有機溶剤の微粒子を製造するためのエマルション法 | |
CA1202631A (fr) | Derives de la quinidine, procede de preparation et application en therapeutique | |
FI106926B (fi) | Menetelmä pitkäaikaisesti vapautuvan koostumuksen muodostamiseksi | |
FR2648814A1 (fr) | L'alpha (tert-butyl-aminomethyl-3,4-dichlorobenzyl)thioacetamide, son procede de preparation et son application en therapeutique | |
CA2535463A1 (en) | Octreotide-pamoate and its use in sustained release formulations of water soluble peptides | |
WO2004016580A2 (fr) | Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique | |
FR2830448A1 (fr) | Microspheres biodegradables a liberation prolongee et leur procede de preparation | |
FR2627487A1 (fr) | Nouveau derive de l'acide valproique, procede de preparation de ce compose ainsi que medicament antiepileptique le contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: ROUSSEL UCLAF Effective date: 19981130 |